PG
PFE icon

Pendal Group’s Pfizer PFE Stock Holding History

Pendal Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$11.2M Buy
218,255
+40,813
+23% +$1.96M 0.1% 117
2022
Q3 		$7.76M Sell
177,442
-19,618
-10% -$953K 0.08% 118
2022
Q2 		$10.3M Sell
197,060
-57,866
-23% -$2.95M 0.1% 112
2022
Q1 		$13.2M Buy
254,926
+25,083
+11% +$1.3M 0.11% 110
2021
Q4 		$13.6M Sell
229,843
-10,215
-4% -$506K 0.11% 110
2021
Q3 		$10.3M Sell
240,058
-93,946
-28% -$4.16M 0.09% 116
2021
Q2 		$13.1M Buy
334,004
+53,470
+19% +$2.08M 0.12% 95
2021
Q1 		$10.2M Sell
280,534
-1,797
-0.6% -$63.8K 0.1% 100
2020
Q4 		$10.4M Sell
282,331
-165,456
-37% -$6.07M 0.11% 87
2020
Q3 		$15.6M Sell
447,787
-167,350
-27% -$5.87M 0.19% 61
2020
Q2 		$19.1M Buy
615,137
+69,605
+13% +$2.36M 0.26% 53
2020
Q1 		$16.9M Buy
545,532
+26,497
+5% +$903K 0.29% 49
2019
Q4 		$19.3M Sell
519,035
-16,057
-3% -$572K 0.25% 52
2019
Q3 		$18.2M Sell
535,092
-63,084
-11% -$2.29M 0.24% 54
2019
Q2 		$24.5M Sell
598,176
-247,361
-29% -$9.82M 0.34% 51
2019
Q1 		$34.1M Buy
845,537
+113,854
+16% +$4.56M 0.47% 48
2018
Q4 		$30.2M Buy
731,683
+123,642
+20% +$5.13M 0.48% 51
2018
Q3 		$25.4M Buy
608,041
+257,910
+74% +$9.93M 0.35% 53
2018
Q2 		$12.1M Buy
350,131
+74,418
+27% +$2.54M 0.16% 99
2018
Q1 		$9.28M Sell
275,713
-434,067
-61% -$14.9M 0.12% 122
2017
Q4 		$24.4M Sell
709,780
-22,943
-3% -$782K 0.32% 54
2017
Q3 		$24.9M Buy
732,723
+227,286
+45% +$7.3M 0.32% 58
2017
Q2 		$16.1M Buy
+505,437
New +$15.9M 0.23% 80

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Pendal Group's PFE Position: Q4 2022 in Review

Pendal Group increased its Pfizer (PFE) stake by 23% in Q4 2022, buying an estimated $1.96M and bringing the position to 218,255 shares worth $11.2M. The position accounts for 0.1% of the portfolio, ranked #117.

Pendal Group first reported a position in PFE in Q2 2017 and has held it in 23 quarters since. The position peaked at $34.1M in Q1 2019. 3,265 funds tracked by Wall St. Rank hold PFE as of Q4 2022.

  • Pendal Group held 218,255 shares of Pfizer worth $11.2M as of Q4 2022.
  • Pendal Group bought 40,813 Pfizer shares in Q4 2022, an estimated $1.96M.
  • Pfizer made up 0.1% of Pendal Group's portfolio in Q4 2022, its #117 holding.
  • Pendal Group first reported a position in Pfizer in Q2 2017 and has held it in 23 quarters since.
  • Pendal Group's Pfizer position peaked at $34.1M in Q1 2019.
  • 3,265 funds tracked by Wall St. Rank held Pfizer as of Q4 2022.

Based on Pendal Group's 13F filing for Q4 2022, filed 19 Jan 2023.